Farzad Nazem Overview
- Investor Type
-
Angel
- Status
-
Active
- Professionals
-
1
- Investments
-
79
- Portfolio
-
22
- Exits
-
50
Farzad Nazem General Information
Description
Mr. Farzad Nazem serves as Advisor at SignalFire. Mr. Nazem is an Angel Investor. He serves as a Board Member at Nautilus Biotechnology. He also serves as a Strategic Advisor at January AI. He earned a B.S. degree in Computer Science with highest honors. He serves on the boards of NextBio and HAND Foundation. He is the former Chief Technology Officer of Yahoo! Inc. At Yahoo, he also served as Executive Vice President of Engineering & Site Operations, Senior Vice President of Communications & Technical Services, and Senior Vice President of Product Development & Site Operations. Before Yahoo, Zod held several technical and executive management positions at Oracle Corporation, including Vice President of Oracle's Media and Web Server Division. He earned a B.S. degree in Computer Science with highest honors from California Polytechnic State University.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Silicon Valley
- San Francisco, CA
- United States
Farzad Nazem Investments (79)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Arrcus | 10-Jul-2023 | Later Stage VC | Business/Productivity Software | Generating Revenue | ||
| GEn1E Lifesciences | 21-Dec-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| January | 15-Aug-2022 | Clinics/Outpatient Services | Generating Revenue | |||
| Persephone (Drug Discovery) | 13-Jul-2022 | Drug Discovery | Generating Revenue | |||
| Trackonomy | 14-Oct-2021 | Business/Productivity Software | Generating Revenue | |||
| Zenda | 29-Oct-2020 | Financial Software | Generating Revenue | |||
| Atomwise | 02-Jul-2018 | Drug Discovery | Pre-Clinical Trials | |||
| Ceevra | 30-Jun-2018 | Decision/Risk Analysis | Generating Revenue | |||
| NoRedInk | 22-Mar-2018 | Later Stage VC | Educational and Training Services (B2C) | Generating Revenue | ||
| TigerGraph | 18-Sep-2017 | Later Stage VC | Database Software | Generating Revenue |
Farzad Nazem Exits (50)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| BioAge Labs | 26-Sep-2024 | IPO | |
| Amitree | 15-Feb-2024 | ||
| Imprint Energy | 29-Aug-2023 | ||
| Zenda | 07-Aug-2023 | ||
| Prodea | 01-Jun-2023 | ||
| Hāpara | 24-Jan-2023 | ||
| Arterys | 03-Oct-2022 | ||
| Rigetti Computing | 02-Mar-2022 | ||
| Ginkgo Bioworks | 17-Sep-2021 | Reverse Merger | |
| Edge Intelligence (Business/Productivity Software) | 16-Aug-2021 | Merger/Acquisition |
Farzad Nazem Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Farzad Nazem Co-Investors (70)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Clear Ventures | 2 |
|
|
||
| EDBI |
|
|
|||
| General Catalyst |
|
|
|||
| Khosla Ventures |
|
|
|||
| SVB Financial Group |
|
|
Farzad Nazem FAQs
-
Who is Farzad Nazem?
Farzad Nazem is an angel Investor who has made 79 investments.
-
What kind of investor is Farzad Nazem?
Farzad Nazem is an angel investor.
-
What does Farzad Nazem do?
As an angel investor, Farzad Nazem invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Farzad Nazem hold?
Farzad Nazem holds a board seat in Nautilus Biotechnology.
-
What has Farzad Nazem invested in?
Farzad Nazem has made numerous investments in companies like Arrcus, GEn1E Lifesciences, and January within the Business/Productivity Software, Drug Discovery, and Clinics/Outpatient Services industries.
-
What has Farzad Nazem invested in recently?
Farzad Nazem's latest investment was on 10-Jul-2023 in Arrcus, a company within the Business/Productivity Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
